155 related articles for article (PubMed ID: 22342542)
1. Synthesis of D-ring-substituted (5'R)- and (5'S)-17β-pyrazolinylandrostene epimers and comparison of their potential anticancer activities.
Iványi Z; Szabó N; Huber J; Wölfling J; Zupkó I; Szécsi M; Wittmann T; Schneider G
Steroids; 2012 Apr; 77(5):566-74. PubMed ID: 22342542
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of steroidal derivatives containing substituted, fused and spiro pyrazolines.
Romero-López A; Montiel-Smith S; Meza-Reyes S; Merino-Montiel P; Vega-Baez JL
Steroids; 2014 Sep; 87():86-92. PubMed ID: 24928724
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents.
Insuasty B; Montoya A; Becerra D; Quiroga J; Abonia R; Robledo S; Vélez ID; Upegui Y; Nogueras M; Cobo J
Eur J Med Chem; 2013 Sep; 67():252-62. PubMed ID: 23871905
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 1-acetyl-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and evaluation of their anticancer activity.
Özdemir A; Altıntop MD; Kaplancıklı ZA; Turan-Zitouni G; Ciftçi GA; Yıldırım SU
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1221-7. PubMed ID: 23020635
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of regioisomeric 17beta-N-phenylpyrazolyl steroid derivatives and their inhibitory effect on 17alpha-hydroxylase/C(17,20)-lyase.
Iványi Z; Wölfling J; Görbe T; Szécsi M; Wittmann T; Schneider G
Steroids; 2010 Jun; 75(6):450-6. PubMed ID: 20206195
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antiproliferative activity of D-ring substituted steroidal benzamidothiazoles.
Fan NJ; He QR; Duan M; Bai YB; Tang JJ
Steroids; 2016 Aug; 112():103-8. PubMed ID: 27137356
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 17-(4'-formyl)pyrazolylandrosta-5,16-dienes and their derivatives as potent 17α-hydroxylase/C17,20-lyase inhibitors or antiproliferative agents depending on the substitution pattern of the heteroring.
Kovács D; Wölfling J; Szabó N; Szécsi M; Schelz Z; Zupkó I; Frank É
Eur J Med Chem; 2016 Sep; 120():284-95. PubMed ID: 27209562
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, 17α-hydroxylase-C
Banday AH; Shameem SA; Banday JA; Ganaie BA
Anticancer Agents Med Chem; 2018; 18(13):1919-1926. PubMed ID: 29697032
[TBL] [Abstract][Full Text] [Related]
9. An efficient approach to novel 17-5'-(1',2',4')-oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17α-hydroxylase/C₁₇,₂₀-lyase.
Kovács D; Wölfling J; Szabó N; Szécsi M; Kovács I; Zupkó I; Frank E
Eur J Med Chem; 2013; 70():649-60. PubMed ID: 24211641
[TBL] [Abstract][Full Text] [Related]
10. Studies on novel D-ring substituted steroidal pyrazolines as potential anticancer agents.
Banday AH; Mir BP; Lone IH; Suri KA; Kumar HM
Steroids; 2010 Dec; 75(12):805-9. PubMed ID: 20206644
[TBL] [Abstract][Full Text] [Related]
11. Steroselective synthesis of some steroidal oxazolines, as novel potential inhibitors of 17alpha-hydroxylase-C17,20-lyase.
Ondré D; Wölfling J; Tóth I; Szécsi M; Julesz J; Schneider G
Steroids; 2009; 74(13-14):1025-32. PubMed ID: 19666042
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel steroidal pyrazole amides as highly potent anticancer agents.
Huo H; Jiang W; Sun F; Li J; Shi B
Steroids; 2021 Dec; 176():108931. PubMed ID: 34655595
[TBL] [Abstract][Full Text] [Related]
13. Lewis acid-induced intramolecular access to novel steroidal ring D-condensed arylpyrazolines exerting in vitro cell-growth-inhibitory effects.
Mótyán G; Zupkó I; Minorics R; Schneider G; Wölfling J; Frank É
Mol Divers; 2015 Aug; 19(3):511-27. PubMed ID: 25894363
[TBL] [Abstract][Full Text] [Related]
14. N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
Brossard D; Zhang Y; Haider SM; Sgobba M; Khalid M; Legay R; Duterque-Coquillaud M; Galera P; Rault S; Dallemagne P; Moslemi S; El Kihel L
Chem Biol Drug Des; 2013 Nov; 82(5):620-9. PubMed ID: 23906044
[TBL] [Abstract][Full Text] [Related]
15. Design and stereoselective synthesis of novel isosteviol-fused pyrazolines and pyrazoles as potential anticancer agents.
Zhu SL; Wu Y; Liu CJ; Wei CY; Tao JC; Liu HM
Eur J Med Chem; 2013 Jul; 65():70-82. PubMed ID: 23693151
[TBL] [Abstract][Full Text] [Related]
16. Facile and efficient access to Androsten-17-(1',3',4')-pyrazoles and Androst-17β-(1',3',4')-pyrazoles via Vilsmeier reagents, and their antiproliferative activity evaluation in vitro.
Li J; Huo H; Guo R; Liu B; Li L; Dan W; Xiao X; Zhang J; Shi B
Eur J Med Chem; 2017 Apr; 130():1-14. PubMed ID: 28237792
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferative activity of some steroidal thiosemicarbazones, semicarbazones and hydrozones.
Gan C; Cui J; Su S; Lin Q; Jia L; Fan L; Huang Y
Steroids; 2014 Sep; 87():99-107. PubMed ID: 24928726
[TBL] [Abstract][Full Text] [Related]
18. Efficient access to novel androsteno-17-(1',3',4')-oxadiazoles and 17β-(1',3',4')-thiadiazoles via N-substituted hydrazone and N,N'-disubstituted hydrazine intermediates, and their pharmacological evaluation in vitro.
Kovács D; Wölfling J; Szabó N; Szécsi M; Minorics R; Zupkó I; Frank É
Eur J Med Chem; 2015 Jun; 98():13-29. PubMed ID: 25993309
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic activity of novel 3-(1H-indol-3-yl)-1H-pyrazole-5-carbohydrazide derivatives.
Zhang D; Wang G; Zhao G; Xu W; Huo L
Eur J Med Chem; 2011 Dec; 46(12):5868-77. PubMed ID: 22000925
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anti-tumor evaluation of B-ring substituted steroidal pyrazoline derivatives.
Shamsuzzaman ; Khanam H; Mashrai A; Sherwani A; Owais M; Siddiqui N
Steroids; 2013 Dec; 78(12-13):1263-72. PubMed ID: 24064114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
